Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival
ABSTRACT Objective To evaluate the impact of assistance from public and private health systems on the overall survival of patients with metastatic prostate cancer. Methods A total of 213 patients with metastatic prostate cancer treated at the A.C. Camargo Cancer Center, either in the Unified Hea...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2025-05-01
|
| Series: | Einstein (São Paulo) |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100220&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849314062345699328 |
|---|---|
| author | Amanda Caroline de Souza Costa Fernando Korkes Jose Augusto Rinck Junior Frederico Timóteo Silva Cunha Luciana Holtz de Camargo Barros Stênio de Cássio Zequi Maria Nirvana da Cruz Formiga |
| author_facet | Amanda Caroline de Souza Costa Fernando Korkes Jose Augusto Rinck Junior Frederico Timóteo Silva Cunha Luciana Holtz de Camargo Barros Stênio de Cássio Zequi Maria Nirvana da Cruz Formiga |
| author_sort | Amanda Caroline de Souza Costa |
| collection | DOAJ |
| description | ABSTRACT Objective To evaluate the impact of assistance from public and private health systems on the overall survival of patients with metastatic prostate cancer. Methods A total of 213 patients with metastatic prostate cancer treated at the A.C. Camargo Cancer Center, either in the Unified Health System or a private system, from January 2014 to December 2018 were analyzed. Multivariate analysis of overall survival was performed to adjust for the type of health assistance and other clinical prognostic factors. Results Of 213 included patients, 147 (69%) were from the private system and 66 (31%) were from the Unified Health System. There was a significant difference in the median age at diagnosis between the systems (63.4 years for patients in the private system versus 67.2 years for patients in the Unified Health System, p=0.027). No significant differences in performance status were observed between the groups (p=0.695). Patients treated in the public system had access to fewer treatment lines (2.59 lines in the public system versus 3.04 lines in the private system, p=0.024). Our data revealed a longer median survival for patients with private health care (115 months for patients with private health care versus 78 months for patients in the Unified Health System, p=0.009). Multivariate analysis revealed that patients in the public system had a 66% higher risk of death than those in the private system. Conclusion Our data demonstrate that patients in the Unified Health System have access to fewer lines of therapy for metastatic prostate cancer, resulting in shorter median survival than patients treated in the private system. |
| format | Article |
| id | doaj-art-a2880deb8dee4cbb8ecae39488440d30 |
| institution | Kabale University |
| issn | 2317-6385 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Instituto Israelita de Ensino e Pesquisa Albert Einstein |
| record_format | Article |
| series | Einstein (São Paulo) |
| spelling | doaj-art-a2880deb8dee4cbb8ecae39488440d302025-08-20T03:52:33ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-63852025-05-012310.31744/einstein_journal/2025ao0851Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survivalAmanda Caroline de Souza Costahttps://orcid.org/0009-0003-2427-3476Fernando Korkeshttps://orcid.org/0000-0003-4261-4345Jose Augusto Rinck Juniorhttps://orcid.org/0000-0003-1873-0290Frederico Timóteo Silva Cunhahttps://orcid.org/0000-0002-0731-3734Luciana Holtz de Camargo Barroshttps://orcid.org/0000-0003-2184-044XStênio de Cássio Zequihttps://orcid.org/0000-0003-1897-8085Maria Nirvana da Cruz Formigahttps://orcid.org/0000-0002-1187-1384ABSTRACT Objective To evaluate the impact of assistance from public and private health systems on the overall survival of patients with metastatic prostate cancer. Methods A total of 213 patients with metastatic prostate cancer treated at the A.C. Camargo Cancer Center, either in the Unified Health System or a private system, from January 2014 to December 2018 were analyzed. Multivariate analysis of overall survival was performed to adjust for the type of health assistance and other clinical prognostic factors. Results Of 213 included patients, 147 (69%) were from the private system and 66 (31%) were from the Unified Health System. There was a significant difference in the median age at diagnosis between the systems (63.4 years for patients in the private system versus 67.2 years for patients in the Unified Health System, p=0.027). No significant differences in performance status were observed between the groups (p=0.695). Patients treated in the public system had access to fewer treatment lines (2.59 lines in the public system versus 3.04 lines in the private system, p=0.024). Our data revealed a longer median survival for patients with private health care (115 months for patients with private health care versus 78 months for patients in the Unified Health System, p=0.009). Multivariate analysis revealed that patients in the public system had a 66% higher risk of death than those in the private system. Conclusion Our data demonstrate that patients in the Unified Health System have access to fewer lines of therapy for metastatic prostate cancer, resulting in shorter median survival than patients treated in the private system.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100220&lng=en&tlng=enHealth servicesProstatic neoplasmsNeoplasm metastasisRace factorsSocial determinants of healthHealth systemsSurvival analysisPublic sectorPrivate sectorBrazil |
| spellingShingle | Amanda Caroline de Souza Costa Fernando Korkes Jose Augusto Rinck Junior Frederico Timóteo Silva Cunha Luciana Holtz de Camargo Barros Stênio de Cássio Zequi Maria Nirvana da Cruz Formiga Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival Einstein (São Paulo) Health services Prostatic neoplasms Neoplasm metastasis Race factors Social determinants of health Health systems Survival analysis Public sector Private sector Brazil |
| title | Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival |
| title_full | Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival |
| title_fullStr | Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival |
| title_full_unstemmed | Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival |
| title_short | Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival |
| title_sort | socioeconomic inequities in prostate cancer care private versus public treatment settings pose a significant impact on overall survival |
| topic | Health services Prostatic neoplasms Neoplasm metastasis Race factors Social determinants of health Health systems Survival analysis Public sector Private sector Brazil |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100220&lng=en&tlng=en |
| work_keys_str_mv | AT amandacarolinedesouzacosta socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival AT fernandokorkes socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival AT joseaugustorinckjunior socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival AT fredericotimoteosilvacunha socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival AT lucianaholtzdecamargobarros socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival AT steniodecassiozequi socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival AT marianirvanadacruzformiga socioeconomicinequitiesinprostatecancercareprivateversuspublictreatmentsettingsposeasignificantimpactonoverallsurvival |